American Academy of Ophthalmology Meeting
American Academy of Ophthalmology Meeting
Source/Disclosures
Source:

Donnenfeld ED, et al. Refractive outcomes and stability 12 months after implantation of a modular, curvature-changing IOL. Presented at: American Academy of Ophthalmology annual meeting; Nov. 13-15, 2020 (virtual meeting).

Disclosures: Donnenfeld reports he serves on the scientific advisory board of LensGen.
November 23, 2020
1 min read
Save

One-year outcomes show 'excellent' performance of fluid-optic IOL at all distances

Source/Disclosures
Source:

Donnenfeld ED, et al. Refractive outcomes and stability 12 months after implantation of a modular, curvature-changing IOL. Presented at: American Academy of Ophthalmology annual meeting; Nov. 13-15, 2020 (virtual meeting).

Disclosures: Donnenfeld reports he serves on the scientific advisory board of LensGen.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

One-year results show that the Juvene fluid-optic IOL succeeds in providing stable, full range of vision from distance through near, according to a study.

“Of note, there is very little or no glare and halo with this lens,” Eric D. Donnenfeld, MD, said at the virtual American Academy of Ophthalmology annual meeting.

Juvene (LensGen) is a new-concept accommodating IOL that integrates a base lens supported by capsule-filling circumferential haptics and a fluid-optic, curvature-changing lens that allows for continuous range of vision, distance to near. The two lenses can be implanted through a small incision.

Eric D. Donnenfeld

In a 12-month study, 45 eyes were followed for monocular data, and 14 patients were followed for binocular data.

“Monocular results show that all patients had excellent distance visual acuity, 20/25 at least. Intermediate was also excellent, with over 95% achieving 20/25. At near, DCNV was 20/32 for half of the patients, and the great majority achieved 20/40 VA,” Donnenfeld said.

Bilateral implantation provided improved vision at all distances, suggesting binocular summation. Mean best corrected distance vision and intermediate vision were 20/20, and near was 20/32 or better, with almost all patients achieving vision at all three distances.

Defocus curves supported the previous data in all 45 eyes, showing no peaks and troughs but a relatively flat and stable shelf.

“When we look at the binocular defocus curve of 14 patients, we can see that binocular summation does occur, and it is not due to a monovision effect. Distance vision was better than 20/20, intermediate was 20/25, and near was better than 20/40,” Donnenfeld said.